Moors & Cabot’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.75M | Sell |
45,913
-6,433
| -12% | -$574K | 0.18% | 107 |
|
|
2026
Q1 | $3.76M | Sell |
52,346
-46,567
| -47% | -$3.59M | 0.16% | 134 |
|
|
2025
Q4 | $7.85M | Sell |
98,913
-1,948
| -2% | -$154K | 0.34% | 55 |
|
|
2025
Q3 | $7.6M | Sell |
100,861
-247
| -0.2% | -$16.9K | 0.33% | 58 |
|
|
2025
Q2 | $6.97M | Sell |
101,108
-899
| -0.9% | -$59K | 0.32% | 65 |
|
|
2025
Q1 | $6.91M | Sell |
102,007
-1,161
| -1% | -$69.5K | 0.35% | 58 |
|
|
2024
Q4 | $4.63M | Sell |
103,168
-37,746
| -27% | -$2.12M | 0.22% | 90 |
|
|
2024
Q3 | $8.86M | Sell |
140,914
-32,950
| -19% | -$1.92M | 0.44% | 45 |
|
|
2024
Q2 | $10.3M | Sell |
173,864
-22,206
| -11% | -$1.39M | 0.55% | 35 |
|
|
2024
Q1 | $15.6M | Sell |
196,070
-3,425
| -2% | -$262K | 0.85% | 21 |
|
|
2023
Q4 | $15.8M | Buy |
199,495
+3,166
| +2% | +$225K | 0.98% | 14 |
|
|
2023
Q3 | $13.7M | Buy |
196,329
+17,558
| +10% | +$1.24M | 0.93% | 16 |
|
|
2023
Q2 | $12.4M | Buy |
178,771
+1,557
| +0.9% | +$111K | 0.82% | 19 |
|
|
2023
Q1 | $13.2M | Sell |
177,214
-6,718
| -4% | -$563K | 0.91% | 16 |
|
|
2022
Q4 | $17.1M | Sell |
183,932
-8,251
| -4% | -$796K | 1.19% | 11 |
|
|
2022
Q3 | $18.3M | Sell |
192,183
-19,281
| -9% | -$1.91M | 1.4% | 6 |
|
|
2022
Q2 | $19.6M | Sell |
211,464
-2,387
| -1% | -$233K | 1.41% | 7 |
|
|
2022
Q1 | $21.6M | Sell |
213,851
-8,542
| -4% | -$897K | 1.33% | 8 |
|
|
2021
Q4 | $22.9M | Buy |
222,393
+4,392
| +2% | +$406K | 1.41% | 6 |
|
|
2021
Q3 | $18.5M | Sell |
218,001
-1,285
| -0.6% | -$108K | 1.16% | 11 |
|
|
2021
Q2 | $18.3M | Buy |
219,286
+3,043
| +1% | +$249K | 1.28% | 10 |
|
|
2021
Q1 | $16.3M | Buy |
216,243
+7,042
| +3% | +$513K | 1.25% | 10 |
|
|
2020
Q4 | $14.3M | Sell |
209,201
-2,156
| -1% | -$140K | 1.2% | 11 |
|
|
2020
Q3 | $12.3M | Buy |
211,357
+15,536
| +8% | +$967K | 1.16% | 11 |
|
|
2020
Q2 | $12.7M | Buy |
195,821
+41,610
| +27% | +$2.62M | 1.35% | 10 |
|
|
2020
Q1 | $9.18M | Sell |
154,211
-1,069
| -0.7% | -$71.4K | 1.33% | 8 |
|
|
2019
Q4 | $11.5M | Buy |
155,280
+5,267
| +4% | +$370K | 1.16% | 13 |
|
|
2019
Q3 | $9.48M | Buy |
150,013
+31,578
| +27% | +$1.87M | 1.04% | 17 |
|
|
2019
Q2 | $6.43M | Buy |
118,435
+16,728
| +16% | +$901K | 0.82% | 24 |
|
|
2019
Q1 | $5.47M | Buy |
101,707
+46,768
| +85% | +$2.89M | 0.74% | 26 |
|
|
2018
Q4 | $3.61M | Buy |
54,939
+1,485
| +3% | +$111K | 0.57% | 40 |
|
|
2018
Q3 | $4.22M | Buy |
53,454
+465
| +0.9% | +$33.2K | 0.52% | 46 |
|
|
2018
Q2 | $3.4M | Sell |
52,989
-410
| -0.8% | -$27K | 0.46% | 54 |
|
|
2018
Q1 | $3.32M | Sell |
53,399
-1,219
| -2% | -$87.5K | 0.44% | 58 |
|
|
2017
Q4 | $3.97M | Sell |
54,618
-5,233
| -9% | -$380K | 0.53% | 43 |
|
|
2017
Q3 | $4.85M | Buy |
59,851
+6,715
| +13% | +$531K | 0.7% | 23 |
|
|
2017
Q2 | $4.26M | Buy |
53,136
+2,028
| +4% | +$160K | 0.71% | 24 |
|
|
2017
Q1 | $4.04M | Sell |
51,108
-1,658
| -3% | -$132K | 0.68% | 27 |
|
|
2016
Q4 | $4.17M | Buy |
52,766
+870
| +2% | +$70.4K | 0.69% | 25 |
|
|
2016
Q3 | $4.62M | Buy |
51,896
+1,115
| +2% | +$105K | 0.77% | 19 |
|
|
2016
Q2 | $4.87M | Buy |
50,781
+2,861
| +6% | +$285K | 0.86% | 16 |
|
|
2016
Q1 | $4.98M | Sell |
47,920
-3,275
| -6% | -$318K | 0.9% | 17 |
|
|
2015
Q4 | $5.01M | Sell |
51,195
-4,234
| -8% | -$415K | 0.92% | 16 |
|
|
2015
Q3 | $5.34M | Buy |
55,429
+1,969
| +4% | +$207K | 0.99% | 12 |
|
|
2015
Q2 | $5.59M | Buy |
53,460
+3,141
| +6% | +$321K | 0.91% | 18 |
|
|
2015
Q1 | $5.2M | Buy |
50,319
+650
| +1% | +$65.8K | 0.87% | 20 |
|
|
2014
Q4 | $4.77M | Buy |
49,669
+679
| +1% | +$59.8K | 0.81% | 21 |
|
|
2014
Q3 | $3.91M | Buy |
48,990
+1,212
| +3% | +$95.5K | 0.66% | 31 |
|
|
2014
Q2 | $3.62M | Buy |
47,778
+15,059
| +46% | +$1.14M | 0.61% | 37 |
|
|
2014
Q1 | $2.45M | Buy |
+32,719
| New | +$2.31M | 0.62% | 39 |
|
Other funds holding CVS
Moors & Cabot's CVS Position: Q2 2026 in Review
Moors & Cabot reduced its CVS Health (CVS) stake by 12% in Q2 2026, selling an estimated $574K and leaving 45,913 shares worth $4.75M. The position accounts for 0.18% of the portfolio, ranked #107.
Moors & Cabot first reported a position in CVS in Q1 2014 and has held it in 50 quarters since. The position peaked at $22.9M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Moors & Cabot held 45,913 shares of CVS Health worth $4.75M as of Q2 2026.
- Moors & Cabot sold 6,433 CVS Health shares in Q2 2026, an estimated $574K.
- CVS Health made up 0.18% of Moors & Cabot's portfolio in Q2 2026, its #107 holding.
- Moors & Cabot first reported a position in CVS Health in Q1 2014 and has held it in 50 quarters since.
- Moors & Cabot's CVS Health position peaked at $22.9M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.